A trial vaccine for Covid-19 being developed by Oxford scientists could produce a greater antibody response in larger doses, a study involving pigs suggests.
The ChAdOx1 nCoV-19 vaccine, being developed by the University of Oxford, is currently undergoing human trials.
Work with the Purbright Institute in Woking to test the vaccine on pigs found that two doses of the trial vaccine resulted in a marked increase in neutralising antibodies that block infection.
Prof Simon Graham, lead author of the study, said: “While it remains to be determined what immune responses are required to effectively protect people against Covid-19, the demonstration that ChAdOx1 nCoV-19 induces both neutralising antibody and T cell responses is very encouraging.”
The best of the Muslim Times’ collection for war against Covid 19:
In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.
For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology
For the latest health news from BBC, Please click here
The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources
For the number of cases and epidemiology in each country go to: WorldOMeters
DAILY NEW CASES AND DEATHS IN US, CDC SITE